Document is current

Article History

Received: 6 October 2024

Accepted: 30 October 2025

First Online: 4 December 2025

Declaration

:

: Ethical approval was issued by the Ethics Committee for Research Involving Medicinal Products in Valladolid Health Area (CEIm Área de Salud Valladolid Este) --responsible of ethical approvals for the University of Valladolid in 2022--, code PI_22-2713_NO_HCUV.

: Prior to enrollment, each potential participant received a written informed-consent form that clearly outlined the study’s objectives, procedure, and expected duration, along with details on data confidentiality and how results would be used. The form stressed that taking part was entirely voluntary. It also underscored the right of revocation: participants could withdraw their consent and discontinue involvement at any moment, and they could request that any data already collected from them be excluded from the analysis without needing to provide a reason.

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.